Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
45.76
+0.86 (1.92%)
Sep 22, 2026, 2:32 PM EDT - Market open
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Ionis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $83.82. The average 1-year stock price forecast is 83.17% higher than the current stock price, while the lowest is $54 (+18.01%) and the highest is $105 (+129.46%).
Price Target: $83.82 (+83.17%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 10 | 10 | 10 |
| Buy | 8 | 9 | 8 | 9 | 9 | 9 |
| Hold | 5 | 5 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 26 | 24 | 23 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $70 | Buy | Reiterates | $70 | +52.97% | Sep 22, 2026 |
| Barclays | Barclays | Buy Maintains $85 | Buy | Maintains | $85 | +85.75% | Sep 18, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $89 → $80 | Buy | Maintains | $89 → $80 | +74.83% | Sep 15, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $69 → $56 | Hold | Maintains | $69 → $56 | +22.38% | Sep 14, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $93 → $91 | Buy | Maintains | $93 → $91 | +98.86% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
921.42M
from 943.71M
Decreased by -2.36%
Revenue Next Year
1.38B
from 921.42M
Increased by 49.56%
EPS This Year
-2.70
from -1.54
EPS Next Year
-1.11
from -2.70
EPS and Forward PE are based on non-GAAP adjusted numbers.